Neuro-Sys

Neuro-Sys is a Paris-based, globally recognized CRO focused exclusively on neurodegenerative and neurological disease research. The company leverages a suite of proprietary preclinical models and platforms to offer bespoke study services, from target validation to drug development support. Having recently expanded into a large, state-of-the-art facility and won industry awards, Neuro-Sys is positioned as a specialized partner in a high-need therapeutic area. Its business model is entirely service-based, generating revenue through client-funded research projects.

Integrated suite of preclinical platforms including in vitro (cell-based models), in vivo (rodent models), histology, EMG, biomolecular/analytical analysis, and drug development (PK/PD, BBB) platforms for neurodegenerative disease research.

Neuro-Sys competes in the preclinical CRO market, facing large, diversified players like Charles River and Labcorp, as well as other neuroscience-focused CROs. Its differentiation lies in its exclusive focus on neurodegenerative diseases, high rate of bespoke model development, and deep scientific expertise, as recognized by its recent award. It competes on specialization and scientific quality rather than scale alone.